GB0406546D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0406546D0
GB0406546D0 GB0406546A GB0406546A GB0406546D0 GB 0406546 D0 GB0406546 D0 GB 0406546D0 GB 0406546 A GB0406546 A GB 0406546A GB 0406546 A GB0406546 A GB 0406546A GB 0406546 D0 GB0406546 D0 GB 0406546D0
Authority
GB
Grant status
Grant
Patent type
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0406546A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

GB0406546A 2004-03-24 2004-03-24 Combination therapy Ceased GB0406546D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0406546A GB0406546D0 (en) 2004-03-24 2004-03-24 Combination therapy

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GB0406546A GB0406546D0 (en) 2004-03-24 2004-03-24 Combination therapy
PCT/GB2004/002932 WO2005004870A1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
KR20067000464A KR20060033782A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CN 200480025738 CN100425240C (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi
DE200460028834 DE602004028834D1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative vascular permeability ZD6474 in combination with platinum compounds and optional ionizing radiation in the treatment of diseases associated with angiogenesis and / or increased
KR20127017256A KR20120093411A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
EP20040743275 EP1648465B1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
US10563668 US20060167027A1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
JP2006518352A JP2007526886A (en) 2003-07-10 2004-07-07 In the treatment of angiogenesis and / or vascular hyperpermeability in diseases associated with the use of a quinazoline derivative zd6474 in combination platinum-based antineoplastic agents and any ionizing radiation
CA 2531862 CA2531862C (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
US12624760 US20100215773A1 (en) 2003-07-10 2009-11-24 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
US13294152 US20120263802A1 (en) 2003-07-10 2011-11-10 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability

Publications (1)

Publication Number Publication Date
GB0406546D0 true GB0406546D0 (en) 2004-04-28

Family

ID=32188555

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0406546A Ceased GB0406546D0 (en) 2004-03-24 2004-03-24 Combination therapy

Country Status (1)

Country Link
GB (1) GB0406546D0 (en)

Similar Documents

Publication Publication Date Title
GB0516732D0 (en) Therapeutic agent
GB0508153D0 (en) Therapeutic agent
GB0521139D0 (en) Therapeutic agent
GB0516091D0 (en) Therapeutic agent
GB0414759D0 (en) "Fitting"
GB0404319D0 (en) Fitting
DK1759141T4 (en) Fitting
GB0406728D0 (en) Gene therapy
DE602005026498D1 (en) R prothese
GB0413172D0 (en) Stop
GB0416097D0 (en) Combinations
GB0418486D0 (en) Dexx+ crum-buster
GB0401033D0 (en) Improved small solarium
GB0406708D0 (en) Coffin
GB0419597D0 (en) Resuscitators
GB2415909B (en) Medical Aid
GB0417840D0 (en) Two
GB0405970D0 (en) Concept seven
GB0424400D0 (en) Inhaler
GB0413081D0 (en) Inhaler
GB0407990D0 (en) Inhaler
GB0426910D0 (en) Inhaler
GB0423511D0 (en) Inhaler
GB0406253D0 (en) Concept 12 - twelve
GB0423908D0 (en) Ten

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)